Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $33.4550 (-1.68%) ($33.4550 - $33.9900) on Wed. May. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.38% (three month average) | RSI | 63 | Latest Price | $33.4550(-1.68%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO advances 3.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(40%) IWO(38%) IWM(37%) IWN(35%) SDY(34%) | Factors Impacting HALO price | HALO will decline at least -1.69% in a week (0% probabilities). UUP(-13%) TBT(-9%) BNDX(-9%) IGOV(-8%) VXX(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.69% (StdDev 3.38%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $33.95(-1.46%) | 10 Day Moving Average | $33.67(-0.64%) | 20 Day Moving Average | $32.79(2.03%) | To recent high | -32.5% | To recent low | 10.9% | Market Cap | $4.572b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |